Galenica raises $242M bond to refinance maturing debt
What's the deal? GalenicaDealroom has a profile for this one. Try Dealroom →, Switzerland's largest integrated healthcare network, has placed a US$183.3M four-year bond at an annual coupon of 1.2775%. Deutsche Bank and Zurich Cantonal Bank acted as joint lead managers, with Basel Cantonal Bank as co-manager.
Why now? The proceeds will refinance a bond maturing in 2026, with the remainder going to general corporate purposes. It follows a US$229.2M, seven-year issue in November 2025 that helped refinance bridge financing for Galenica's Labor TeamDealroom has a profile for this one. Try Dealroom → acquisition.
What's the endgame? This is routine treasury management rather than a new strategic push. The company is staggering its debt maturities while keeping access to the Swiss-franc bond market open.
Galenica operates more than 20 companies across the healthcare value chain, including Switzerland's densest pharmacy network of over 380 sites. It employs more than 8,000 people and reported net sales of US$3.76B in 2025.
The new coupon of 1.2775% sits above the 1.08% on the 2025 bond, though different issue dates and maturities limit any direct comparison. The bond is expected to be admitted to trading on the SIX Swiss Exchange shortly.
The signal: At roughly $242 million, the raise ranks in the top tier by size — above the 88th percentile among comparable rounds. For Galenica, though, the headline is less the amount than the ease of placement: a signal that investor appetite for its debt remains steady as it manages maturities ahead of its 2026 results update in January.
Read more: webdisclosure.com
Image credit: Generated with Gemini
